The Effects of Antifracture Therapies on the Components of Bone Strength: Assessment of Fracture Risk Today and in the Future
K. Shawn Davison(University of Victoria), Jacques P. Brown(Centre hospitalier de l'Université Laval), Louis-George Ste-Marie(Hôpital Saint-Luc), David L. Kendler(University of British Columbia), Robert G. Josse(Western University), David Goltzman(Tel Aviv University), Stéphanie Kaiser(Dalhousie University), David A. Hanley(The University of Sydney), Αλεξάνδρα Παπαϊωάννου(Western University), Jonathan D. Adachi(St. Peter's Hospital), Kerry Siminoski, Wojciech P. Olszynski(University of Saskatchewan), Alan Tenenhouse(St. Vincent's Birmingham), Anthony B. Hodsman(Western University)
Cited by 18
Related Papers
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2001|4.6k
Body mass index as a predictor of fracture risk: A meta-analysis
|Osteoporosis International|2005|1.6k
Common genetic determinants of vitamin D insufficiency: a genome-wide association study
|The Lancet|2010|1.5k
Predictive Value of BMD for Hip and Other Fractures
|Journal of Bone and Mineral Research|2005|1.5k